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The results of previous studies (1) (2) (3) have shown that pneumonia virus of mice (PVM) is a latent infectious agent present in the lungs of apparently normal mice, but capable of producing fatal pulmonary infection in animals of at least three species. That this virus is widely disseminated in nature was indicated by the finding of neutralizing antibodies against it in serum obtained from certain members of nine mammalian species, including man (3) .
The obscure activity of this latent pneumotropic virus, its unusual properties, and its apparent widespread distribution have seemed sufficiently interesting to warrant further investigation. It appeared possible that additional information concerning the agent might yield knowledge of value in the study of respiratory infections, and perhaps serve also to elucidate the r61e in such diseases of latent infectious agents.
The discovery (4, 5) that influenza viruses possess the capacity to agglutinate erythrocytes provided a valuable tool for the study of these agents. It is now known that certain other viruses, including those of vaccinia (6) , Newcastle disease (7) , fowl plague (8) , and mumps (9) are also capable of agglutinating erythrocytes.
Recently Mills and Dochez (10) discovered that suspensions of lungs from mice infected with a virus which appears to be identical with pneumonia virus of mice, could agglutinate mouse erythrocytes, but only after the suspensions had been heated. Their finding suggested that hemagglutination might be usefully applied to the study of PVM, and the phenomenon was therefore investigated further.
* The Bureau of Medicine and Surgery of the U. S. Navy does not necessarily undertake to endorse the views or opinions which are expressed in this paper.
The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and The Rockefeller Institute for Medical Research.
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It is the purpose of this paper to present the results of studies concerning the hemagglutination reaction obtained with suspensions of lungs infected with pneumonia virus of mice. Certain properties of the component responsible for hemagglutination in PVM suspensions will be described and evidence assembled which indicates that this component is, in fact, the virus. Moreover, it will be shown that hemagglutination is but one manifestation of an unusual combination which occurs between the virus and a substance derived from certain tissues of the host.
Methods
Vir~.--Pneumoifia virus of mice, strain 15 (1) as well as the strain described by Mills and Dochez (I0), l was used. The hemagglutinating and infectious properties of these two strains showed no greater differences than were found with various preparations of strain 15 itself. By cross-neutralization and cross-immunity tests they were indistinguishable, and the available evidence indicates that both are strains of the same virus as was suggested by the findings of Mills and Dochez (10) . In the present study, certain experiments were carried out with each strain, and both are included in the designation, PVM, which will be used hereafter in referring to this agent.
The techniques used for titrations of virus and neutralization tests with PVM were identical with those described in a preceding paper (2) as also was the method for the calculation of 50 per cent maximun score (M.S.50) end points.
Preparation of Lung Suspensions.--The lungs of Swiss mice which had been inoculated
intranasally with PVM were removed with aseptic precautions. The lungs were pooled and ground, either immediately or after varying periods of storage at -70°C. Grinding was carried out either in a mortar or in a Waring blendor. Lungs were weighed and prepared as 10 per cent suspensions in saline or beef infusion broth. Aliquots of such unheated or native suspensions were centrifuged at low speed, and the supernates tested for infectivity, while other aliquots were heated at an appropriate temperature, then centrifuged, and the supernates tested for hemagglutination. Throughout this report the term, heated PVM, refers to heated suspensions of infected mouse lungs prepared as described above. Similar suspensions of lungs from cotton rats and hamsters which had been infected with PVM were prepared and tested. For certain experiments suspensions of lungs from apparently normal mice, cotton rats, hamsters, and rabbits were prepared and tested in an identical manner.
Satisfactory suspensions were obtained when fresh lungs from mice infected with PVM or similar lungs stored for varying periods of time at -70°C. were ground as described above, and diluted with saline or broth. Suspensions heated at 80°C. for 10 minutes, or 70°C. for 30 minutes gave comparable titers. Suspensions heated at these temperatures coagulated into a chocolate colored mass and were non-infectious. By means of centrifugation a waterclear or slightly brownish tinged supernate was obtained and used in hemagglutination tests.
In tests for hemaggiutination, mouse RBC in 0.8 per cent suspensions were optimal. Suspensions of heated PVM and 0.8 per cent mouse RBC in volumes of 0.2 cc. each weresatisfactory. Agglutination of mouse RBC by heated PVM was maximal after mixtures had stood at room temperature for 2 hours.
Initially some di~culty was encountered in determining titration end points, because of slight autoagglutination of mouse erythrocytes. This dit~culty was eliminated by including in the RBC suspension 1.0 per cent of normal horse serum which had been treated as described above. The horse serum used for this purpose contained no neutralizing antibodies against PVM.
When suspensions of heated PVM in serial twofold dilutions and mouse RBC were mixed and allowed to stand at room temperature, the RBC aggregated slowly and settled to the bottom of the tubes. Only in the lower dilutions, usually not greater than 1:16, were large clumps or compact discs observed. Agglutination of this character was recorded as 4. In the next higher dilutions, small agglutinated particles accumulated upon the walls and the curved bottom of the tube. Such agglutination, recorded as 3, was observed over the greatest range of dilution. A lesser, but definite degree of agglutination was recorded as 2, and minimal agglutination visible without a lens as 1. Even when agglutination was maximal, the aggregated cells could be easily and completely dispersed by agitating the tubes. Following such dispersal agglutination recurred, and titrations recorded under such circumstances closely approximated the values originally observed.
The hemagglutination titer was taken as the highest dilution of a PVM suspension which gave a reaction recorded as 2. Since 10 per cent lung suspensions were used as a routine the actual titer of the hemagglutinating component was tenfold higher than that recorded for the suspension. Throughout this paper whenever hemagglutination and virus titers are compared both are expressed in terms of the final dilution of infected lung.
FJytt~ocytes.--Suspensions of lungs from mice infected with PVM were tested for their capacity to cause agglutination of RBC obtained from eight species. The RBC were tested against both native and appropriately heated aliquots of these suspensions. Erythrocytes from mice, hamsters, rabbits, cotton rats, guinea pigs, dogs, sheep, and chickens, as well as human erythrocytes belonging to each of the four major blood groups were used.
It was found that definite agglutination of either mouse or hamster RBC, occurred with every appropriately heated suspension of PVM prepared with lungs obtained from mice 4 to 8 days after inoculation with the virus. In parallel titrations of heated PVM against both mouse and hamster RBC, agglutination occurred at a dilution two to four times greater in the presence of RBC from mice as compared with RBC from hamsters. With hamster erythrocytes, no spontaneous agglutination was noted, and the inclusion of heated normal horse serum in suspensions of these RBC was unnecessary. Agglutination of mouse or hamster RBC by heated suspensions of lungs from apparently normal mice, with but rare exceptions was not observed. Agglutination of these cells by native suspensions of PVM was not seen. Agglutination did not occur with native or heated suspensions of PVM and cotton rat, guinea pig, dog, rabbit, sheep, chicken, or human erythrocytes.
As was shown in a preceding paper (3), intranasal inoculation with PVM induces pulmonary consolidation, and even fatal pneumonia in cotton rats and hamsters, which do not possess antibodies against the virus. Heated suspensions prepared from the consolidated lungs of cotton rats or hamsters infected with PVM agglutinated mouse and hamster RBC, but not cotton rat RBC. Agglutination of mouse, hamster, or cotton rat RBC by heated suspensions of lungs from apparently normal cotton rats, hamster, or rabbits was not observed with the exception of one suspension of hamster lungs which in low dilution agglutinated mouse RBC. Agglutination of mouse, hamster, or cotton rat RBC by native suspensions of either normal or infected hamster or cotton rat lungs was never observed.
It appears that appropriately heated suspensions of consolidated lungs obtained from mice, hamsters, or cotton rats infected with PVM cause agglutination of RBC from mice and hamsters, but not RBC from any other species tested. The findings suggest that the agglutination observed was attributable to the presence of PVM. The agglutination of mouse RBC which in rare instances was observed with heated lung suspensions from apparently normal mice and hamsters was neither surprising nor inconsistent with the hypothesis that the agglutination was attributable to the presence of PVM. As was shown in a preceding paper (3), either this virus or one similar to it appears to be harbored in the lungs of apparently normal animals of both species, and it might be expected that this latent agent would cause hemagglutination when present in sufficient concentration. Suspensions of normal lungs which caused hemagglutination were obtained from old animals and, in certain instances, it was shown that these animals had in their serum a high titer of neutralizing antibody against PVM, indicating that they had been infected by it.
Thermal Requirements.--One of the most interesting features of the hemagglutination phenomenon with PVM was the finding (10) that suspensions of infected mouse lungs required an extraordinary exposure to heat before hemagglutination was demonstrable. An attempt was made to obtain additional information concerning the thermal requirements for the manifestation of this property.
Suspensions of PVM mouse lungs were divided into aliquots which were heated at different temperatures for various periods of time. Following centrifugation the supernates of each aliquot were tested for their capacity to agglutinate mouse RBC.
The results obtained in a typical experiment are presented in Table I , which shows the hemagglutination titer of each aliquot of a PVM suspension heated as indicated. It will be noted that at progressively higher temperatures shorter periods of heating were required to reveal the hemagglutinating property and to achieve maximal titer. For practical purposes heating at 70~C. was optimal; at this temperature maximal titer was attained after a short time, and was not significantly altered after considerably longer periods. These data indicate not only that heating is required to disclose the hemagglutinating property of PVM suspensions, but also that at high temperatures, at which this property is quickly made manifest, it is destroyed if the period of heating is prolonged.
The data indicate that the time required for maximal release of the corn- 
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Fro. 1. Relation between time and temperature required for release of hemagglutinating component. T --absolute temperature, t --time in minutes. ponent responsible for hemagglutination, hereinafter designated as component A;
was inversely related to the temperature. When the logarithm of the reciprocal of the time of heating was plotted against the reciprocal of the absolute temperature, it was found that the relation between these two variables was strictly linear within the range studied, in Fig. 1 are presented graphically the'results derived from the experiment just described. It is evident that the straight line which was drawn closely approximates aU of the experimentally determined points, and that no systematic deviation from this line occurs.
Combination between Component A and Tissue Cdls.--It seemed of importance to determinewhether the hemagglutinating component actually combined with mouse erythrocytes; whether such a combination was stable or underwent spontaneous dissociation, and if stable, whether the component could be released by appropriate heating.
Heated PVM and 6.0 per cent mouse RBC were mixed and held at 37°C. Aliquots were removed at the time of mixing and at intervals thereafter. The supernate of each aliquot, following centrifugation, was tested for hemagglutination. The sedimented RBC of each aliquot were resuspended in saline, heated at 80°C. for 10 minutes, centrifuged, and the superhates also tested for hemagglutination.
The results of such an experiment are shown in Fig. 2 . It can be seen that component A was removed from the supemate rapidly, and was carried down with the sedimented RBC. The rapidity with which combination occurred is indicated at 0 on the time scale by the reduction in the hemagglutination titer of the supernate, as well as by the hemagglutinating capacity of the sedimented RBC in the aliquot tested immediately after mixing. More than 90 per cent of component A was removed from the supernate by the RBC in 1 hour, after 4 hours over 98 per cent was removed, and from 12 to 48 hours after preparation of the mixture no hemagglutination was demonstrable with the supernates. It is noteworthy that from 1 to 48 hours after mixing all or almost all of the component was demonstrable in the RBC sediment.
In a similar experiment carried out at 4°C., combination with RBC occurred somewhat more slowly, and less completely. It was found that combination with hamster RBC occurred in a manner comparable to that observed with mouse RBC.
The results indicate that component A united with mouse erythrocytes during the process of agglutination and remained in firm combination with them for at least 48 hours at either 37 or 4°C. No evidence of spontaneous dissociation of the c0mbmation was observed, but release of the component from agglutinated RBC was accomplished by appropriate heating. Component A following release was still capable of agglutinating fresh RBC.
Similar experiments with chick and cotton rat RBC, and with crystalline alundum showed no evidence of any union of component A with these RBC or with alundum particles. This indicates that combination as well as agglutination occurred only with the erythrocytes of certain species, e.g. mouse and hamster, and suggests that both phenomena are dependent upon the presence and availability of a particular substance or reactive group in RBC, obtained from these species.
Additional experiments were carried out to determine what fraction of mouse RBC was capable of combining with the component A. It was found that solutions of laked erythrocytes from which the stromata had been removed, did not inhibit the hemagglutination reaction. On the other hand, the component combined with washed stromata as rapidly and as completely as with intact RBC, and similarly no spontaneous dissociation was demonstrable. Moreover, the component could be released from stromata by appropriate heating.
These findings indicate that with mouse erythrocytes the substance responsible for combination with the hemagglutinating component resides in the cell stroma, and that combination with this substance is the first step in the reaction which results in hemagglutination.
It seemed of interest to determine whether component A could combine with tissue cells other than erythrocytes. The fact that heating was required to release this component with PVM lung suspensions derived not only from the mouse or hamster, but also from the cotton rat suggested that combination occurred with a constituent of cells in the lung other than RBC.
Mice and cotton rats were exsangninated, and a 10 per cent suspension of RBC from each species was prepared as previously described. The lungs and specimens of muscle were removed from exsanguinated animals of both species and 10 per cent suspensions of each tissue were prepared in saline. A portion of the cotton rat lung suspensions was centrifuged, the supemate removed, and the sediment resuspended to volume. Aliquots of heated PVM Saline. 256 256~ * 0 = no agglutination at PVM dilution of 1-4. There was no sediment obtained from these mixtures. The titer shown is that of an aliquot heated as indicated. suspension were mixed in equal volumes with each of the RBC and tissue suspensions and hdd at 26°C. for 2 hours. Similar mixtures with the supernate and resuspeuded sediment of the cotton rat lung suspension were held for 20 hours. The mixtures were then centrifuged at 8,000 mP.M., the supemates removed, and tested for hemagglutination. The sediments were resuspended to volume in saline, heated at 80°C. for 10 minutes, recentrifuged, and the supemates tested similarly.
The results of one such experiment are shown in Table II . Each of the tissues derived from the mouse combined with the hemagglutinating component. With lung and muscle all of the component was removed from the supernate and with RBC approximately 98 per cent was removed. In each instance, the component was demonstrated in the sediment, and the quantities recovered indicated no great loss in view of the necessary manipulations.
The somewhat lower titer obtained with the RBC sediment is consistent with the results of similar tests shown in Fig. 2 .
With mixtures of heated PVM and the supernate of the cotton rat lung suspension the results were identical with those obtained with the mixture containing the unfractionated lung suspension. On the other hand, with the resuspended sediment of cotton rat lung no hemagglutination was produced by the unheated supernate, whereas hemagglutination in undiminished titer was shown by the heated aliquot containing the sedimented tissue. Thus, the sedimentable material present in the cotton rat lung suspension possessed the capacity to combine with the hemagglutinating component, but was not capable of destroying this component as was the unfractionated lung SUSpension and its supernate.
These results indicated that in normal cotton rat lung as opposed to muscle a substance derived from cells other than RBC was capable of combining with component A, and that, following appropriate heating, the component couldbe released from union with this substance.
Similar experiments were carried out with various materials obtained from normal chick embryos. It was found that allantoic and amniotic fluid, as well as suspensions of embryo tissue and RBC were not capable of combining with the hemagglutinating component. In this connection it is of interest to recall that chick embryos are completely resistant to infection by PVM (3).
Comparison of Native and Heated PVM
To obtain additional information concerning the component in PVM mouse lung suspensions responsible for hemagglutination, certain properties of native and heated PVM were studied. Every effort was made to compare the properties of the native and heated preparations in as quantitative a manner as possible, in order to discover whether or not the virus and component A were similarly constituted.
Concentration of PVM and Component A in Infected Mouse Lungs.--Exper-
iments were carried out to determine the amounts of PVM and component A present in the lungs of mice at different intervals following intranasal inoculation of the virus.
Young Swiss mice were inoculated with PVtVI by the intranasal route. In certain experiments the mice were inoculated with different dilutions of virus, whereas in other experiments the inocula contained a constant dilution of virus and varying dilutions of normal or immune serum. As mice do not die of infection with PVM until 5 or 6 days following inoculation, some of the mice were killed in order to obtain lungs at intervals of 2 and 4 days following inoculation. Lungs of infected mice obtained from 2 to 12 days after inoculation were used in these experiments. All of the lungs tested from mice which died showed complete pulmonary consolidation. The lungs of mice killed 2 days after inoculation only rarely showed a trace of consolidation, whereas in lungs from mice killed 4 or 6 days after inoculation definite pneumonia was almost invariably present. The lungs of mice killed 11 or 12 days after inocu-lation showed great variations in the incidence and extent of pulmonary lesions; only lungs showing extensive consolidation were tested.
The lungs of mice obtained after each interval were pooled and stored at --70°C.; ultimately they were ground and made into 10 per cent suspensions in the usual manner. Viras titrations were carried out as described above. Hemagglutination tests against mouse PBC were performed with each suspension following appropriate heating. The results of these experiments are presented in Table III . It is evident that during the 1st week, the titer of virus in the lungs of infected mice increased, and reached a maximum at 6 or 7 days. After longer intervals the virus titer progressively decreased, and, in the lungs of mice which died or were killed 12 days after inoculation, virus was usually not demonstrable. It will also be noted that the capacity of heated suspensions to produce hemagglutination similarly increased to a maximum at 6 to 7 days following inoculation and progressively decreased thereafter. With suspensions prepared from lungs of mice 11 or,12 days after inoculation hemagglutination was usually not observed. Day'~ following inoculation FIO. 3. Relation of virus and hemagghitlnation titers of mouse lung suspensions to time following inoculation.
In Fig. 3 the logarithms of the geometric mean titers of virus infectivity (M.S.50) and hemagglutination obtained for all suspensions prepared at each interval following inoculation are presented graphically. It will be noted that there is a close correspondence between the two curves, and that both the virus and the hemagglutination titers varied in almost identical manner with time following inoculation. In the light of the data presented in a preceding paper (2) regarding the reproducibility of virus titration end points with PVM, and the well known experimental errors of in r~ro titrations based upon serial dilutions, it seems evident that at none of the time intervals was there a significant difference between the vires and the hemagglutination titers.
The striking decrease in both the virus and the hemagglutination titers which was observed from the 8th to the 12th day after inoculation with PVM was unexpected. With influenza A virus, Taylor (11) observed a similar, although less marked reduction in virus titer from the 7th to the 10th day after inoculation. Attempts were made to obtain an explanation for the rapid disappearance of demonstrable PVM from completely consolidated lungs of mice. In neutralization tests carried out with lung suspensions obtained at intervals up to 12 days after inoculation, no evidence for a progressive incroase in the concentration of neutralizing antibody in the lungs was found. Moreover, when serial dilutions of suspensions, prepared from the lungs of mice 11 or 12 days after inoculation, were tested no virus was demonstrable. The results of previous studies (2) as well as direct tests with neutral mixtures of PVM and antiserum against it, indicate that on dilution of such mixtures dissociation occurs and apparently neutralized virus becomes capable of inducing manifest infection. The results of these tests suggest that the progressive diminution in virus titer which occurred from the 8th through the 12th day following inoculation could not be explained exclusively on the basis of neutralization by antibody produced in response to the infection. It appears that the concentration of PVM actually decreased during the later stages of the infectious process, and it seems possible that one ormore enzymes present in the lung tissue may have inactivated the virus.
Effect of Enzymes upon P VM and Component
A.--In the course of these experiments evidence was obtained which indicated that suspensions of certain normal tissues, including lung, possessed the capacity to destroy the hemagglutinating property of heated PVM suspensions. On the presumption that this effect was the result of enzymatic action, experiments were carried out to determine the effect of certain highly purified enzymes upon PVM and component A.
Saline solutions of crystalline trypsin, chymotrypsin, and ribonuclease as well as a highly purified preparation of desoxyribonuclease s in concentrations of 1.0 nag. per cc. were each mixed with equal volumes of heated PVM. Corresponding mixtures were also made with each enzyme and a similar suspension of normal mouse lungs; in each instance the pH was approximately 7.0 The mixtures were held at 370C. for 1 hour, and then divided into two portions, one of which was lmated at 80°C. for 10 minutes to destroy enzymatic activity. The unheated and heated portions of each mixture were tested in the usual manner for their capacity to agglutinate mouse RBC.
The results of such an experiment are shown in Table IV . None of the mixtures containing normal mouse lung and ~ibonuclease, desoxyribonuclease, or saline produced hemagglutination. Unheated mixtures containing trypsin or chymotrypsin, however, caused some hemagglutination, whereas following heating, this effect was abolished. From the results of other experiments it appears that the presence of trypsin or chymotrypsin causes mouse RBC to agglutinate.
With mixtures of heated PVM and ribonuclease or desoxyribonuclease there
The enzyme preparations used in these experiments were kindly provided by Lieutenant Commander Maclyn MeCarty (MC) U. S. N. R.
was no significant reduction of the hemagglutination titer. Similar mixtures containing either trypsin or chymotrypsin, when tested unheated, showed hemagglutination titers almost identical with those of the corresponding normal lung mixtures, but following heating no hemagglutination was demonstrable. Similar results were obtained in experiments in which the concentration of enzyme as well as the time and temperature of reaction was varied. A concentration of 0.1 mg. per cc. of either trypsin or chymotrypsin was sufficient to destroy completely the capacity of heated PVM suspensions to cause hemagglutination. Experiments were also carried out to determine the effect of the same enzymes upon the virus and hemagglutinating component in native PVM suspensions.
Native PVM mouse lung suspensions were mixed in equal volumes with each of the enzymes previously employed and in the same concentration (i.e. 1.0 rag. per cc.). The pH of these these mixtures was approximately 7.0 In different experiments the mixtures were held at temperatures of 10-37°C. for periods of time varying from 1 to 44 hours. The virus titer of each mixture was determined in the usual manner in mice and corresponding aliquots after appropriate heating were tested for hemagglutination.
The results of one experiment in which the mixtures were held at 10°C. for 22 hours are shown in Table V . The mixtures containing trypsin and chymotrypsin were found to be completely non-infectious, indicating more than a 200-fold reduction in virus titer, and their capacity to cause hemagglutination was reduced by approximately 75 and 80 per cent, respectively. In mixtures with ribonuclease and desoxyribonuclease, the virus titers were not significantly reduced and the hemaggintination titers were identical with those of the controls.
The results of similar experiments carried out under conditions more favorable to enzymatic activity indicated that trypsin and chymotrypsin could render native PVM suspensions completely incapable of causing hemagglutination. Under such circumstances, however, because of the instability of PVM, there was a marked loss of virus titer in other mixtures including the controls, and the effect of the two proteolytic enzymes upon the property of infectiousness was therefore less apparent. Among the enzymes tested only trypsin and chymotrypsin caused significant reductions of both virus and hemagglutinating activity and whenever the hemagglutinating activity was appreciably reduced all infectiousness was invariably lost. With mixtures containing PVM and either of these two enzymes in which the virus apparently had been rendered non-infectious, there was no indication that the virus was reactivated by dilution.
From the results of these experiments it appears that both trypsin and chymotrypsin have the capacity to render native PVM suspensions completely n0n-infectious and incapable of causing hemagglutination. As might be anticipated the themolabile property of infectiousness appears to be more susceptible to enzymatic inactivation than the thermostable capacity to cause hemagglutination. The loss of hemagglutinating activity with mixtures of of PVM and trypsin or chymotrypsin in vitro indicates that these enzymes act upon the virus suspension directly, and suggests that the loss of infectiousness also results from alteration of the virus and not from an effect upon the host.
Stability of PVM and Component
A.--The results of previous experiments (2) indicated that PVM is a relatively unstable vires. Suspensions of infected mouse lungs held at room temperature for 24 hours completely lost the capacity to induce pulmonary consolidation, and with various preparations held at 56°C. for 10 to 30 minutes the property of infectiousness was entirely destroyed.
As was shown above, however, the component responsible for hemagglutination was extraordinarily thermostable. It was not destroyed by heat greatly in excess of that necessary to destroy the property of infectiousness. Moreover, suspensions of PVM which were no longer infectious as a result of prolonged exposure to temperatures of 25 or 37°C., when tested following appropriate heating, showed undiminished capacity to produce hemagglutination. Heated PVM suspensions stored either at room temperature or 4°C. showed no loss in hemagglutination titer when tested after periods of 6 months and 1 year, respectively. Such suspensions also showed no loss of hemagglutination titer in buffer solutions over a pH range from 5 to 9.6. The capacity to produce hemagglutinatiou was quickly destroyed, however, at pH 3 and 10.5
g gezt of Dia2ysis upon PVM and Component A.--In several experiments prolonged dialysis
of PVlVI mouse lung suspensions against repeated changes of distilled water at I0°C. caused no reduction in the concentration of component A in the dialyzed suspension. This was true with both native and heated PVM. In the process of dialysis, however, the virus completely lost the property of infectiousness. Consequently, no direct comparison of virus and hemagghitination titers was possible following this procedure. Of interest, was the finding that component A was water-insoluble, and in the course of prolonged dialysis was completely precipitated.
Effezt of Fi2tvation.--As reported earlier (1) PVM is filterable through Berkfeld N candies.
It was observed, however, that such filtration resulted in a decrease in titer of approximately 1.0 log unit; a loss of 90 per cent of the virus. When aliquots of suspensions and filtrates prepared from them were appropriately heated, and tested, the filtrates showed a reduction in hemagglutination titer which corresponded closely to the decrease in virus titer. With heated PVlVl lung suspensions, the component responsible for hemagghitination passed readily through Berkfeld N candles, without any appreciable reduction in concentration.
Effect of Centrifugation upon PVM and Component A.--Previous ultrafiltra-
tion experiments (1) with PVM indicated that the virus had a diameter of approximately 100 to 150 millimicrons. It seemed possible by means of centrifugation to obtain information concerning the relative sizes of the infectious unit, and of component A in PVM lung suspensions, and, of more importance, to determine whether or not the hemagglutinating component could be separated from the virus.
As shown in a preceding paper (2) approximately 80 per cent of the virus was sedimented under the influence of relatively low gravitational fields;
i.e., 8,000 R.P.M. It was found that component A in unheated suspensions was similarly sedimented.
Tubes containing 7.0 cc. of either native or heated PVIVI mouse lung suspension were centrifuged in an electrically driven angle centrifuge (12) at 4°C. Following eentrifugation the top 3.5 cc. of superuate were removed and the sediment resuspended in the remainder of the centrifuged suspension; i.e., 3.5 cc. Aliquots of the superuate and resuspended sediment from the native PVlVI suspension were titered in mice for infectivity, and corresponding allquota after appropriate heating were tested for hemagglutination. The supemate and resuspended sediment of the heated PVlVl suspension were also tested for hemagglutination.
The results of a typical experiment are presented in Table VI . After centrifugation of native PVM at 15,000 R.P.M. for 15 minutes, less than 5 per cent of either the virus or component A was demonstrable in the supernate. Evidently over 95 per cent of both the virus and component A in the native PVM suspension had been sedimented from the upper half of the tube by the gravitational force applied. On the other hand, centrifugation of heated PVM at 17,000 R.P.~. for 15 minutes caused no significant sedimentation of component A.
From this and other similar experiments it appeared that following centrifugation of native PVM suspensions, irrespective of the speed or time employed, the concentrations of virus and of component A in the supernate and sediment corresponded as closely as could be expected within the limitations of the methods used for testing and no indication was obtained that the virus and component A could be separated by centrifugation. On the other hand, with Thus, it appears that component A in heated preparations is considerably smaller than the infectious particles in unheated PVM suspensions. The findings suggest that in native PVM lung suspensions, the virus itself, like component A, is combined with a substance derived from tissue of the host. Under such circumstances it would appear that the infectious particles represent not virus alone, but a complex consisting of virus, and a substance from host tissue.
A ntigenicity of PVM and Component A .--Previous experiments (1) showed that PVM is capable of inducing active immunity in mice, and of stimulating the development of neutralizing antibodies in rabbits. It seemed important to ascertain whether or not heated PVM retains specific antigenicity for these species.
Each mouse in a group was injected intraperitoneally with 0.5 cc. of heated PVM. Suspensions heated at different temperatures for varying periods of time were used. In each experiment the mice of a control group received no intraperitoneal injections. 14 days after the intraperitoncal injection, a titration of PVM was carried out in each group.
The results of such an experiment are shown in Table VII. In the control mice, the M.S. 50 end point was 10-3.% In mice injected with PVM which had been heated at 80°C. for 10 minutes the M.S. 50 end point was 10 -°.~ or less, indicating immunity to at least 2,300 M.S. 50 doses of virus. In mice injected with the same PVM suspension, heated, however, at 80°C. for 2 hours there was evidence of much less resistance to infection, since they were immune to only 14 M.S. 50 doses of virus.
In other experiments the degree of immunity induced was less striking, but all the results indicated that the specific antigenicity of PVM was extraordinarily resistant to prolonged heating at high temperatures, and in one experiment boiling for 15 minutes did not entirely destroy it.
Experiments were also carried out to determine whether heated PVM is capable of inducing in rabbits the formation of neutralizing antibodies against this virus.
Rabbits were given a single intraperltoneal injection of PVlVl heated at 80°C. for 10 minutes. Other rabbits were similarly injected with the same suspension of PVM, which had been heated at 80°C. for 4} hours. Additional rabbits were injected with preparations of Streptococcus saUvaeius as a control. Sera obtained from each animal at two intervals before and 3 weeks following injection were tested for their capacity to neutralize PVM.
The results of such an experiment are shown in Table VIII . It will be noted that 6 weeks before injection, none of the animals had demonstrable neutralizing antibodies against PVM, whereas 1 week before injection, neutralizing antibodies were present. The titers, however, were with but few exceptions of a relatively low order, comparable to those frequently found in the serum of apparently normal animals upon arrival in the laboratory (3).
3 weeks following injection, the rabbits which received PVM, heated for 10 minutes, showed on the average a 64--fold increase in neutralizing antibodies. Rabbits which received PVM heated for 4½ hours, showed on the average an eight fold increase in neutralizing antibodies.
In the control group the titers did not increase in a single instance. It seems evident from the results obtained in rabbits as well as in mice that heated PVM was specifically antigenic, and that the antigenic capacity was somewhat more thermostable than the component responsible for hemagglutination. (10) showed that hemagglutination produced by heated PVM could be inhibited by specific immune serum. This observation was readily confirmed. Experiments were undertaken to place the reaction on a quantitative basis, and to correlate the capacity of a serum to inhibit hemagglutination with its capacity to neutralize the active virus.
Inhibition of Hemagglutination.--Mills and Dochez
Tests were carried out by mixing 0.2 cc. of serial twofold dilutions of serum with 0.2 cc. of a constant dilution of heated PVM, allowing the mixtures to react at room temperature for 30 minutes, followed by the addition of 0.4 cc. of mouse RBC suspension prepared as described above. The highest serum dilution in which no hemagglutination occurred was taken as the end point. In order to obtain reliable results with this method, it was essential to absorb serum with mouse ceils to remove agglutinins for mouse RBC (I0). The amount of heated PVM added was determined by the hemagglutiuation titer of the suspension; the highest dilution in which agglutination recorded as 2 occurred was taken as oneunit. Usually a dilution of heated PVM corresponding to 8 or more units was employed.
The results of typical agglutination-inhibition tests with serum from immune rabbits are shown in Table IX . Sera which possessed neutralizing antibodies against PVM were capable of inhibiting hemagglutination caused by heated PVM, whereas sera which did not contain such antibodies were incapable of Influenza B virus agglutination inhibition titer was, normal 96; immune 3000. § 0 --agglutination inhibition titer of 8 or less; neutralization titer of less than 2.
inhibiting this reaction. These findings serve to illustrate the specificity of the agglutination-inhibition reaction with heated PVM, and to indicate the relatively close correlation between the capacity of each serum to inhibit agglutination, and to neutralize the virus. A quantitative analysis of this correlation with serum obtained from normal and immune animals of several species is presented below.
Complement Fixation with PVM and Component A.
--Efforts to demonstrate specific fixation of complement by mixtures of unheated PVM mouse lung suspensions and immune serum have in the past consistently failed. Since appropriate heating of PVM suspensions made manifest the property of hemagglutination, an attempt was made to determine whether heated PVM suspensions were capable of causing specific complement fixation in the presence of immune serum.
Superuates of native and heated saline suspensions prepared with lungs of normal mice and lungs of similar mice which died with complete pulmonary consolidation following infection with PVIVI were used as antigens in the complement fixation tests. Heated antigens prepared from normal lungs did not cause agglutination of mouse RBC, whereas heated antigens prepared from lungs of mice infected with PVM gave heanagglutinatlon at dilutions of 1:256 or more.
Serum was inwctivated by heating at 56°C. for 30 minutes and was then centrifuged at I0,000 ~.P.M. for 20 minutes. Serial twofold dilutions of serum were made in saline. To 0.2 cc. of each serum dilution was added 0.2 cc. of the desired antigen, and 0.3 cc. of saline containing 2 units of guinea pig complement. The mixtures were incubated in a water bath at 37.5°C. for 1 hour, after which 0.7 cc. of sensitized sheep ceils was added --0.5 cc. of 2 per cent sheep cells and 0.2 c¢. of saline containing 2 units of amboceptor. The mixtures were again incubated in the water bath for 30 minutes, and the degre, of hemolysis was then estimated. Appropriate hemolytic and anticomplementry controls were included. Complement fi~tion titers were expressed in terms of the highest initial serum dilution mixture in which no hemolysis occurred.
The results of typical complement fixation tests with mouse lung antigens and. immune serum are presented in Table X . With heated antigens complement fixation occurred only in mixtures which contained PVM and serum which possessed neutralizing antibodies against this virus. The serum of cotton rats recovered from intranasal infection with PVM, although capable in high dilution of neutralizing the virus, was incapable of causing fixation of complement in the presence of native PVM antigen, but gave complement fixation in the presence of the same antigen following heating. The serum of rabbits immunized by intraperitoneal injection of mouse lung suspensions gave complement fixation as was expected, in the presence of native antigens prepared from either normal or infected mice. Absorption of such serum with normal mouse tissues causeti them to lose this capacity but did not remove their capacity to fix complement with heated PVM. With the serum of rabbits which had developed neutralizing antibodies as a result of latent infection, complement fixation occurred only in the presence of heated PVM antigen. Heating at 100°C. for 15 minutes did not completely destroy the component in PVM suspensions responsible for specific fixation of complement.
These results indicate clearly that specific fixation of complement was demonstrable with mixtures of heated PVM and specific immune serum. It is of particular interest that native PVM suspensions failed to give complement fixation under identical conditions. It appears evident that the component responsible for complement fixation, like that responsible for hemagglutination, was masked in the unheated suspension, and that both specific properties became manifest following adequate heating.
Correlation between Virus and Hemagglutinatlon Titers.--The results of the experiments described above indicated a close association 'between the virus itself, and the component in PVM mouse lungs responsible for hemagglutination. Attempts were made to determine whether hemagglutination was a property of the virus particle itself, or was dependent upon some substance distinct from the virus. If hemagglutination were a property of the virus, it would be expected that there should be a close correlation between the virus and the hemagglutinatiou titers.
The results of experiments devised to test this correlation as well as the results of experiments involving widely varied treatment of PVM lung suspensions were assembled for analysis. Titration end points on 44 separate preparations are presented graphically in Fig. 4 , in which the logarithm of the virus titer (M,S. 50) of each suspension was plotted against the logarithm of the hemagglutination titer. Each point on the graph was determined by the results of independent titrations of the same suspension employing two entirely different techniques.
The great majority of the points are distributed along a straight line which has a slope of 1.0, and intercepts both axes at zero. The broken lines which were drawn parallel to this line indicate a theoretical deviation of 4-log 0.3 which approximates the mean experimental error of each titration technique. From the slope of the line, it is apparent that points falling along it represent equivalent values as measured on either axis.
STUDIES ON PN~UMONLA VIRUS OF MICE (PV'M). Ill
Most of the points shown in Fig. 4 are distributed along the line within the limits of technical error, and with the exception of five points, the scatter is similiar on both sides. Five of the total of 44 points deviate significantly (2) from the line, and each does so because the virus titer was considerably lower than would have been expected from the hemagglutination titer. Since it is evident that non-infectious preparations retain their capacity to cause hemaggiutination, it seems reasonable to suggest that these discrepancies in correlation may have been due to the presence of non-infectious virus in the suspensions in question. substances present in approximately equivalent amounts. In view of the large number of variables, the latter alternative is highly improbable. It seems likely, therefore, that both methods measure the same component, and as one is a measurement of virus concentration, it appears logical to think that the other is also. The results of this analysis indicate that titration of hemagglutination caused by heated PVM can be used as an in v/tro method for the estimation of virus concentration.
Correlation o.f RBC Agglutination-Inhibition and Neutralization Titers.--
Specimens of serum from rabbits, cotton rats, and mice were tested for their capacity to neutralize PVM, and also for their capacity to inhibit hemagglutination caused by heated PVM. Serum from normal animals, and from animals of each species which had been immunized with PVM was used. The logarithm of the neutralization titer (M.S. 50) determined against approximately 32 M.S. 50 doses of virus, was plotted against the logarithm of the agglutinationinhibition titer, determined against 8 agglutinating units of heated PVM The results obtained by these two different techniques on 60 specimens of serum are presented graphically in Fig. 5 . It will be noted that as the neutralization titers increased, the agglutination-inhibition titers increased in a proportionate manner; although the latter were somewhat higher than the former, there was a reasonably close parallelism between the titers determined by both techniques with each serum. A straight line, with a slope equal to 1.0, which appeared best to fit the experimental points was drawn. Parallel to this line two other lines were drawn which bound an area corresponding to -4-log 0.3 from the center line along both axes. Consequently, any point failing within this area does not deviate from the center line by a titer difference of more than twofold. The mean experimental errors of either serum neutralization titer (2) or agglutination-inhibition titers against PVM have been found to be of the order of 4-log 0.3, but the error in any single titration may be twice this large. It is of interest that 63 per cent of the points shown fall within the area indicative of the mean experimental error of either technique, and that 88 per cent of the points fall within an area which does not exceed twice this value. It will be seen that certain sera with very low neutralization titers gave agglutination-inhibition titers slightly higher than was expected, while other sera with very high neutralization titers gave agglutination-inhibition titers somewhat lower than was anticipated. Despite these minor discrepancies, the correlation between the results of these two very different methods was good, and with the sera studied, it was possible to estimate with reasonable accuracy from the agglutination-inhibition titer the level of neutralizing antibodies against PVM.
It has been found that agglutination-inhibition titers vary inversely with the quantity of heated PVM used. The relationship between the inhibition titer and the number of agglutinating units used to determine it, appeared to be strictly linear, and based on multiple proportions. Thus, a fourfold increase in the number of agglutinating units caused, almost without exception, a fourfold decrease in the observed inhibition titer. The agglutinationinhibition titers shown in Fig. 5 were determined against 8 agglutinating units, whereas the neutralization titers were determined against approximately 32 M.S. 50 doses of virus. It can be seen, from the intercept on the vertical axis, that the inhibition titers were, on the average, four times higher than the neutralization titers. When the inhibition titers shown were recalculated in terms of 32 agglutinating units, the line intercepted both axes at zero; that is, the mean inhibition titer was equal to the mean neutralization titer. It was shown in Fig. 4 that the virus titer of a suspension was approximately equal therefore, that in the presence of a constant number of virus particles the sera tested gave almost identical titration end points by either the in vitro or the in vivo technique.
P~SU~ AND DISCUSSION
The study of viruses which affect animals and human beings has been seriously handicapped by the necessity of detecting the presence of viruses, and measuring their activity in terms of the manifestations of infection they induce in susceptible species. In vitro methods which would overcome this limitation have long been desired and much sought. A means to attain this objective, in the case of the influenza viruses, was provided by the discovery (4, 5) that these viruses cause agglutination of erythrocytes, and that such hemagglutination is inhibited by specific immune serum. Similar bemagglutination has since been found to be manifested also by several other viruses (5-9).
Mills and Dochez (10) showed that suspensions of mouse lungs infected with PVM could cause agglutination of mouse RBC, provided that the suspensions had been adequately heated. This surprising observation raised the possibility of new and unexpected applications of the hemagglutination technique, and suggested that the phenomenon might be useful in the study of this latent pneumotropic virus.
The component responsible for hemagglutination in heated PVM suspensions could be the virus itself, ~ constituent of lung tissue, or some other substance present in infected lungs. In the light of the experiments described in this paper, the latter two alternatives appear to be very unlikely. Hemagglutination is invariably demonstrable with appropriately heated suspensions of consolidated lungs removed from infected animals 4 to 8 days after inoculation with PVM. Similar preparations of lungs from normal animals or those infected with other viruses fail to cause hemagglutination except in rare instances in which there is reason to believe that PVM is actually present as a latent infectious agent (3). With lung suspensions prepared at intervals following the inoculation of mice with PVM, the virus and the hemagglutination titers both increase during the 1st week, and progressively decrease during the 2nd week, until neither the virus nor hemagglutination is demonstrable. Throughout the course of the infection in mice, the virus and the hemagglutination titers appear to be identical. Moreover, PVM suspensions subjected to various experimental procedures which do not destroy the infectiousness of the virus show hemagglutination titers closely similar to the virus titers. With occasional preparations the hemagglutination titer may be significantly higher than the virus titer; the reverse has not been seen. The occurrence of such discrepancies in correlation is readily explained by the presence of non-infectious virus particles. It will be recalled that only active virus is capable of inducing infection, but that suspensions in which the virus has been purposely rendered non-infectious by heat are capable of causing hemagglutination.
Hemagglutination produced by heated PVM suspensions is completely inhibited by specific immune serum capable of neutralizing the virus, but not by serum which contains no antibodies against PVM, or by antiserum against other viruses. Immune serum obtained from mice, cotton rats, or hamsters following either natural inapparent, or purposely induced infection by PVM inhibits hemagglutination as completely as does the serum of animals immunized by injection of the virus. The antibody titer of immune serum as determined by the hemagglutination-inhibition technique appears to be closely similar to that determined by the virus neutralization technique; the resuits of calculations indicate that when a constant quantity of PVM suspension is used in both tests the observed serum titers are practically identical.
Heated PVM suspensions retain all of the immunological properties which specifically characterize the virus. They induce in mice the development of active immunity against infection by PVM, and stimulate in rabbits the production of specific neutralizing antibodies against the virus. Such suspensions are also capable of fixing complement in the presence of specific immune serum which neutralizes the virus and inhibits hemagglutination. It is of particular interest that this property, like that of hemagglutination, is not demonstrable with PVM suspensions until they have been appropriately heated.
The capacity to produce hemagglutination in either native or heated PVM suspensions appears to be destroyed by either one of two crystalline proteolytic enzymes (i.e. trypsin and chymotrypsin), but not by either of two other highly purified enzymes (i.e. ribonuclease and desoxyribonuclease). The available evidence indicates that the virus itself is rendered completely non-infectious by either of the same two proteolytic enzymes, whereas its activity is not significantly impaired by either of the two nucleases.
Physical procedures which do not destroy the infectiousness of PVM appear not to effect a separation between the virus and the component responsible for hemagglutination; with native PVM suspensions both are sedimented in like amount under the influence of gravitational fields and both are similarly reduced in concentration following passage through filters.
When the results of the many different observations and experimental procedures are considered together, the evidence strongly suggests that the phenomenon of hemagglutirmtion as seen with PVM is due to the virus particle itself. If this is the case it is necessary to account for the fact that native PVM suspensions which invariably fail to cause hemagglutination, manifest this property after appropriate heating. From the results of experiments carried out in this study it appears that a satisfactory explanation for this peculiar phenomenon has been obtained.
Since the available evidence indicates that the hemagglutinating component in PVM lung suspensions is the virus, it would appear that, before or during the process of grinding infected lung tissue, the virus combines to form a complex with a substance present in the lung and, as a consequence, becomes incapable of uniting with a similar substance present in mouse and hamster erythrocytes. It was noted by Mills and Dochez (10), and subsequently was observed in this laboratory, that consolidated lungs of mice dying 4 to 8 days after inoculation by PVM show agglutination of RBC exuding from their cut surfaces, whereas similar hemagglutination with normal mouse lungs does not occur. Once such infected lungs are ground, however, the capacity to produce hemagglutination becomes masked, and is not again manifest until the suspension has been heated. When the complex in native PVM suspensions is appropriately heated, the thermolabile tissue substance is destroyed and the virus, although rendered non-infectious, is released from combination, and can recombine with similar tissue substance from a fresh source. When in combination with the tissue substance, the virus, whether infectious or not, is incapable of agglutinating RBC. Moreover, the combination is stable, and evidence of dissociation in the absence of heating has not been obtained. The virus can, however, be released repeatedly by appropriate heating sufficient to destroy the tissue substance and the capacity for combination and hemagglutination again becomes manifest.
Additional evidence that the virus in native PVM suspensions is present in stable combination with another substance is afforded by the results of ultrafiltration and ultracentrifugation studies. The minimum estimated size of the infectious particles of PVM (i.e. complex of virus and tissue substance) is 100 to 150 millimicrons (1). This is several times greater than the present estimate of the size of the hemagglutinating component (i.e. heat-inactivated virus released from combination). Moreover, as would be expected, the infectious particles are not homogeneous with respect to size, whereas the released virus appears to be relatively uniform.
Since PVM in combination with the tissue substance is incapable of causing hemagglutination, it is not surprising that this complex is also incapable of uniting in vitro with antibody specifically directed against the virus. This is indicated by the fact that the virus in combination fails to give fixation of complement, whereas following its release by heat, complement fixation occurs in the presence of immune serum.
The only method now available for detecting the presence of the tissue substance which combines with PVM depends upon its capacity to unite with the virus. This substance is present in mouse and hamster erythrocytes in which it is confined to the stroma. It is also present in lung tissue of cotton rats, although not in their RBC or muscle tissue, and appears to be present in lung tissue of other susceptible species (i.e. mouse and hamster). The substance is not present in RBC of seven mammalian species other than mouse and hamster, nor in the extra embryonic fluids or tissues of developing chick embryos. The absence of the substance in chick embryos which are not susceptible to infection by PVM and its presence in the lungs of mice, hamsters, and cotton rats which are susceptible to pulmonary infection with this virus, suggest that the tissue substance may be an important factor in the pathogenesis of infection by this latent pneumotropic virus. srwms os PNEUMONLA vmvs oF raCE (Pw). m 2. Evidence in wide variety indicates that the component responsible for hemagglutination is the virus particle itself.
3, The virus is capable of combining with a substance present in lung tissue of certain mammalian host species susceptible to infection by PVM. The occurrence of such combination accounts for a number of unusual properties manifested by this pneumotropic virus.
Addendum.--A second communication by Mills and Dochez (13)on the hemagglutination phenomenon discovered by them has appeared. They used the "ES" strain of virus, which appears to be identical with other strains of PVM. Their experiments were in a number of instances similar to some of those described in the present paper. The results we have obtained appear not to be at variance with the results of comparable experiments reported by Mills and Dochez.
